Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLungCancerTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
October 17, 2025
 · 
Reactions
A MyLungCancerTeam Member

That looks scary….Sorry you have this added stress but glad that is not harmful to you.

October 18, 2025
A MyLungCancerTeam Member

My coughing did increase as I went through immuno-chemotherapy, but I never coughed up bloody sputum, much less pieces of the tumors.
Stay positive!
Tony

October 18, 2025
MyLungCancerTeam

While coughing up blood (hemoptysis) is a common symptom affecting about 20% of people with lung cancer, it's important to monitor any changes and keep your healthcare team informed. Your oncologist's observation about the immunotherapy working is encouraging, as this could indicate the treatment is causing tumor breakdown.

Show Full Answer

While coughing up blood (hemoptysis) is a common symptom affecting about 20% of people with lung cancer, it's important to monitor any changes and keep your healthcare team informed. Your oncologist's observation about the immunotherapy working is encouraging, as this could indicate the treatment is causing tumor breakdown.

However, if you cough up more than a few teaspoons of blood, or experience difficulty breathing, dizziness, or chest pain along with coughing, you should seek immediate emergency medical attention. Some MyLungCancerTeam members have reported experiencing significant coughing during their treatment journey. Treatment side effects can vary from person to person, and it's essential to maintain open communication with your healthcare team about any changes in your symptoms or concerns.

October 17, 2025
A MyLungCancerTeam Member

@A MyLungCancerTeam Member, I started mine in 2022. It was Keytruda and was for patients with a PD-L1 score of greater than "1" back then. Mine was a weak "1" and was squamous cell carcinoma. Now they can use Keytruda on just about any NSCLC.

January 15
A MyLungCancerTeam Member

When you had year immunotherapy did you have any PL-D1

January 14

Related Questions

View All

Yes

A MyLungCancerTeam Member asked a question 💭

A MyLungCancerTeam Member asked a question 💭
Wooster, OH

A MyLungCancerTeam Member asked a question 💭
Lake Helen, FL